Swiss National Bank Zentalis Pharmaceuticals, Inc. Transaction History

Swiss National Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$4.09 - $16.13 $29,857 - $117,749	7,300 Added 7.49%	104,700 $428,000
Q4 2023 Feb 06, 2024	SELL	$9.84 - $20.13 $108,240 - $221,430	-11,000 Reduced 10.15%	97,400 $1.48 Million
Q3 2023 Nov 08, 2023	SELL	$19.63 - $28.29 $278,746 - $401,718	-14,200 Reduced 11.58%	108,400 $2.17 Million
Q2 2023 Aug 09, 2023	BUY	$17.41 - $30.05 $419,581 - $724,205	24,100 Added 24.47%	122,600 $3.46 Million
Q1 2023 May 10, 2023	SELL	$16.14 - $24.94 $185,610 - $286,810	-11,500 Reduced 10.45%	98,500 $1.69 Million
Q4 2022 Feb 08, 2023	BUY	$18.07 - $25.6 $36,140 - $51,200	2,000 Added 1.85%	110,000 $2.22 Million
Q2 2022 Aug 09, 2022	BUY	$17.91 - $52.25 $974,304 - $2.84 Million	54,400 Added 101.49%	108,000 $3.04 Million
Q1 2022 May 09, 2022	BUY	$41.58 - $80.89 $166,320 - $323,560	4,000 Added 8.06%	53,600 $2.47 Million
Q4 2021 Feb 08, 2022	BUY	$66.92 - $84.79 $267,680 - $339,160	4,000 Added 8.77%	49,600 $4.17 Million
Q3 2021 Nov 08, 2021	BUY	$46.83 - $73.5 $37,464 - $58,800	800 Added 1.79%	45,600 $3.04 Million
Q2 2021 Aug 06, 2021	BUY	$37.41 - $62.25 $112,229 - $186,750	3,000 Added 7.18%	44,800 $2.38 Million
Q1 2021 May 07, 2021	BUY	$35.69 - $52.72 $39,259 - $57,992	1,100 Added 2.7%	41,800 $1.81 Million
Q4 2020 Feb 05, 2021	BUY	$31.71 - $57.97 $1.29 Million - $2.36 Million	40,700 New	40,700 $2.11 Million

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $166M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.